Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

PED3005 Pharmacogenomics and Pharmacogenetics > Pharmacogenetics in the clinic > Flashcards

Pharmacogenetics in the clinic Flashcards

(58 cards)

Start Studying
1
Q

What factors contribute to variable inter-individual drug response?

A
  • Demographic
  • Environment
  • Co-morbidities
  • Drug-drug interactions
  • Genomic variation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What percentage of patients benefit from drug therapy?

A

30-60%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the percentage of adverse drug reactions (ADRs) that lead to hospitalization?

A

6.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is pharmacogenomics?

A

Study and response of the genetic determinants of drug response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What percentage of phase-dependent metabolism of clinically used drugs is mediated by CYP families 1-3?

A

70-80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What was the first P450 enzyme purified to homogeneity?

A

CYP2B4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What do polymorphic forms of P450s lead to?

A

Development of significant number of adverse drug reactions (ADRs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the cost implication of treating patients with polymorphic forms of P450s?

A

Higher than those with non-polymorphic alleles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What percentage of subjects are non-responders to drug therapy?

A

Around 30-60%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the role of the 10,000 Genomes project?

A

Sequencing the whole genome of families with rare diseases and patients with common sequences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does CPIC stand for?

A

Clinical Pharmacogenomics Implementation Consortium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What proportion of the population carries at least 1 actionable pharmacogenetic variant?

A

98.5% of Whites and 99.1% of African-Americans in the US

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the function of CYP2C19 in relation to clopidogrel?

A

Prodrug requiring activation by CYP2C19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the effect of the 11 genotype on platelet aggregation when treated with clopidogrel?

A

Reduction in platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the genotypes of a CYP2C19 poor metaboliser?

A

2/2
3/3
2/3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the therapeutic outcome for a CYP2C19 poor metaboliser?

A

Avoid clopidogrel if possible; use prasugrel or ticagrelor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

List the options for statins.

A
  • Atorvastatin
  • Fluvastatin
  • Lovastatin
  • Pitavastatin
  • Pravastatin
  • Rosuvastatin
  • Simvastatin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What role does SLOC1B1 play in the metabolism of statins?

A

Facilitates the hepatic uptake of statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the association of the ABCG2 variant p.Q141K with rosuvastatin?

A

Associated with 30-40% reduced protein expression and increased plasma levels of rosuvastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the two most extensively studied variants of CYP2C9?

A
  • CYP2C9*2 (p.R114C)
  • CYP2C9*3 (p.I359L)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is statin induced myopathy?

A

Ranges from mild myalgia to very rare but life-threatening rhabdomyolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What does the SLOC1B1*5 variant indicate?

A

Higher plasma levels cause muscle toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the significance of diplotypes in pharmacogenomics?

A

Haplotype pairs on homologous chromosomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What treatment adjustments are needed for SLOC1B1 decreased function?

Study These Flashcards
A

Treatment varies based on SAMS risk; high, moderate, or low intensity statins

25
What is familial hypercholesterolemia?
Functional mutation in LDLR, APOB, or PCSK9 gene leading to premature coronary artery disease
26
What should be considered for anticoagulation if warfarin is used?
Pharmacogenetic considerations related to CYP2C9
27
What are the typical substrates of CYP2C9?
* Warfarin * Fluvastatin * Tolbutamide * NSAIDs * Phenytoin
28
What is the range of clinical therapeutic doses for warfarin?
0.5 to 20 mg/day
29
What is the difference between R-warfarin and S-warfarin?
S-warfarin is more biologically active and potent than R-warfarin
30
What is the impact of CYP2C9*3 on warfarin dosing?
Increases risk of warfarin-induced bleeding
31
What should be done for a patient with a homozygous *2 allele in CYP2C19?
Expect poorer outcomes when treated with clopidogrel
32
What is the recommendation for a patient with high SAMS risk and SLOC1B1 decreased function?
Treat with 80 mg of Atorvastatin
33
What is the importance of monitoring in familial hypercholesterolemia?
Initiation of early lipid lowering treatment and monitoring in specialist metabolic clinic
34
What percentage of healthy and random controls express the homozygous wild-type CYP2C9 genotype?
60-62%
35
What percentage of patients expressed the CYP2C9 homozygous wild-type genotype when given a low dose of warfarin?
20%
36
By what percentage was the heterozygous CYP2C9 genotype reduced compared to the homozygous wild type?
35-36%
37
What is the percentage increase of patients with at least one defective allele of CYP2C9 when given a low dose of warfarin?
60%
38
What percentage of healthy and random volunteers did not express the CYP2C9 homozygous mutant alleles?
5-6%
39
What is the warfarin dose requirement for homozygous *2/*2 and *3/*3 genotypes of CYP2C9?
~3mg for *2 and ~1mg for *3
40
What is the mean warfarin dose tolerated by individuals with wild-type CYP2C9?
~5mg
41
What is the association between the presence of one or more variant CYP2C9 alleles and warfarin dose requirement?
Low (<1.5 mg) dose requirement
42
What factors are associated with having a low dose requirement for warfarin?
* Increased risk of problems during induction period * Increased risk of major bleeding episodes following induction
43
List additional factors affecting warfarin dose requirement.
* Age * Ethnic origin * Genotype for target enzyme (VKORC1) * Diet and lifestyle factors
44
What is the target enzyme for coumarin anticoagulants including warfarin?
Vitamin K epoxide reductase
45
What polymorphisms in VKORC1 may be relevant to dose requirement?
* Homozygous A-1639 genotype associated with reduced warfarin dose requirements by up to 3mg/day * CYP4F2 contributes to vitamin K metabolism
46
What does the regression equation for warfarin dose account for?
CYP2C9/VKORC1 genotype, age, and height
47
What was the outcome of the EU-PACT clinical trial regarding genotyping for warfarin dosing?
Genotyped group showed INR closer to 2.5 more consistently and spent higher percentage of time in the therapeutic range
48
What is required prior to initiating treatment with abacavir?
Genetic testing for HLA-B*57:01 allele
49
What percentage of patients develop hypersensitivity reactions to abacavir?
Approx. 5%
50
What is the risk associated with the HLA-B*57:01 allele when treated with abacavir?
Increased risk for abacavir hypersensitivity reactions
51
What is the significance of the Mallal study related to HLA-B*57:01?
Confirmed the association of HLA-B*57:01 with abacavir hypersensitivity
52
What is the prevalence of HLA-B*15:02 in the Han Chinese population?
>15%
53
What pharmacogenetic testing is recommended before starting carbamazepine?
Test for HLA-B*15:02 alleles
54
What is the drug metabolized mainly by CYP2D6 that requires genotyping before prescribing?
Eliglustat
55
What is the common genetic defect associated with cystic fibrosis?
Delta F508
56
What is the indication for Atezolizumab?
Treatment of adult patients with locally advanced or metastatic urothelial carcinoma after prior platinum containing chemotherapy
57
What is the significance of the G-1639A and C1173T polymorphisms in CYP4F2?
Associated with lower warfarin dose
58
What does the Predict-1 study show about HLA-B*57:01 screening?
Reduced the incidence of suspected hypersensitivity reactions from 7.8% to 3.4%

PED3005 Pharmacogenomics and Pharmacogenetics (13 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions